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Background: Regulatory T (Treg) cells play an essential role in the maintenance of immune homeostasis in allergic diseases. Objectives: We sought to define the mechanisms underlying induction of tolerance to peanut protein and prevention of the development of peanut allergy. Methods: High or low doses of peanut extract were administered to pups every day for 2 weeks before peanut sensitization and challenge. After challenge, symptoms, Treg cell numbers, and forkhead box protein 3 (Foxp3), T H 2 and T H 17 cytokine, and Tgfb expression in mesenteric lymph node (MLN) CD4
1 T cells and jejunum were monitored. dendritic cells in MLNs were significantly increased. Treg cell suppression was shown to be antigen specific. Foxp3 methylation was increased in peanut extract-sensitized and challenged mice, whereas in tolerized mice levels were significantly reduced. Conclusions: Feeding high doses of peanut to pups induced tolerance to peanut protein. Key words: DNA methylation, regulatory T cells, forkhead box protein 3, tolerance, peanut allergy Peanut allergy is a common and challenging food allergy in Western Europe and the United States. [1] [2] [3] Development of food allergy is the result of the combination of genetic and environmental factors. Genetic variants in a number of genes have been associated with food allergy susceptibility by using candidate gene approaches, including filaggrin genes, the HLA class II gene family (HLA-DRB1, HLA-DQB1, and HLA-DPB1), forkhead box protein 3 (FOXP3), and the NLR family (NLRP3), but results of association analyses have been inconsistent. 4, 5 Clinical and experimental analyses suggest that initiation of food-induced intestinal allergy is regulated by numerous inflammatory cells and mediators. [6] [7] [8] Recently, peanut oral and epicutaneous immunotherapy clinical trials have been performed in children with peanut allergy. 9, 10 However, mechanistic studies of food allergy are necessarily limited because target organ specimens from patients, such as gut tissue (biopsy specimens), are often difficult to obtain on a regular basis. We investigated a well-characterized mouse model of peanut sensitization to manipulate and define the mechanisms underlying induction of oral tolerance to peanut. 6, 7 Oral tolerance is a state of antigen-specific systemic hyporesponsiveness or unresponsiveness to an antigen to which a subject or animal has been previously exposed through the oral route. 11 Oral tolerance has been well studied in patients with autoimmune diseases and has been used in clinical settings for treating patients with autoimmune diseases, such as rheumatoid arthritis 12 and systemic sclerosis. 13 A number of clinical trials are underway examining the efficacy of oral or transcutaneous tolerance induction to peanut. However, the molecular basis underlying development of oral tolerance in food allergy remains to be defined, in particular the role of epigenetic mechanisms. Regulatory T (Treg) cells have been shown to control a number of allergic diseases, including allergic asthma and atopic dermatitis. 14, 15 Here the role of Treg cells in the development of oral tolerance to peanut protein was investigated. We demonstrated that Treg cells played a critical role in induction of oral tolerance to peanut protein and that Foxp3 demethylation was involved in this process.
Induction of tolerance to peanut-induced intestinal inflammation in vivo
Naive 7-day-old pups received daily PE at different doses (0.05 or 0.5 mg/g body weight) by means of gavage with a 24-gauge feeding needle (Fisher Scientific, Pittsburgh, Pa) in a total of volume of 20 mL of PBS for 2 weeks. The doses were chosen based on initial experiments investigating induction of tolerance. Two weeks later, the mice were sensitized and challenged with PE (PE0.05/PE/PE and PE0.5/PE/PE), as previously described. 16 Briefly, mice were sensitized 3 times with 500 mg of PE together with 2.0 mg of alum (Pierce, Rockford, Ill) by means of intraperitoneal injection in a total volume of 100 mL on days 1, 7, and 21. Two weeks later, mice received 20 mg of PE (in 250 mL of PBS) by means of gavage with a 22-gauge feeding needle (Fisher Scientific) every day for 1 week. Twenty-four hours after the last challenge, serum, mesenteric lymph nodes (MLNs), and jejunal tissues were collected and analyzed. Animals were sham-fed and sham-sensitized and PEchallenged (PBS/PBS/PE) or sham-fed and PE-sensitized and challenged (PBS/PE/PE).
Assessment of hypersensitivity reactions
Allergic symptoms were evaluated 30 minutes every day after oral challenge, as previously reported, 17 as follows: 0, no symptoms; 1, scratching and rubbing around the nose and head; 2, puffiness around the eyes and mouth, diarrhea, pilar erecti, reduced activity, and/or decreased activity with increased respiratory rate; 3, wheezing, labored respiration, and cyanosis around the mouth and tail; 4, no activity after prodding or tremor and convulsion; and 5, death. Scoring of symptoms was performed in a blind manner by an independent observer.
Histology
Jejunal tissue was fixed in 10% formalin and processed into paraffin blocks. Anti-CD25 antibody production and purification
Rat anti-CD25 (IL-2Ra) mAb was isolated from the PC61 hybridoma (kindly provided by Dr Ross Kedl, University of Colorado, Aurora, Colo) originally obtained from the American Type Culture Collection (Manassas, Va), as previously described. 18 Protein concentrations were determined from OD at 280 nm. Endotoxin levels in purified antibody clones PC61 and control rat IgG (clone HRPN) were less than 0.1 EU/mL, as assessed by using a Chromogenic LAL endotoxin assay kit (GenScript).
In vivo depletion of Treg cells
In vivo depletion of CD4 1 CD25 1 Treg cells was achieved after intraperitoneal injection of 500 mg of anti-CD25 mAb (clone PC61) on days 221, 21, and 20 (3 times before sensitization or during sensitization on days stated in the experiment). Control mice were injected with 500 mg of rat IgG on the same days as anti-CD25. The doses of anti-CD25 were chosen based on previous reports. 19, 20 Depletion of Treg cells was confirmed by means of flow cytometry after staining of peripheral blood and spleen lymphocytes with anti-CD4 and anti-CD25 (7D4) 1 day after injection of the anti-CD25 antibody.
Measurement of peanut-specific antibody
Serum peanut-specific IgE, IgG 1 , and IgG 2a levels were measured by means of ELISA, as described previously.
17,21
Isolation of mononuclear cells from the MLNs MLN mononuclear cells (MNCs) from BALB/c mice were isolated with a plunger, and cell suspensions were passed through a Falcon cell strainer (70-mm mesh; BD Biosciences, San Jose, Calif).
Flow cytometry
Cells from MLNs or peripheral blood were labeled with anti-CD4 and anti-CD25 antibodies and stained for intracytoplasmic FoxP3 by using an anti-mouse FoxP3 intracellular staining kit (eBioscience, San Diego, Calif), according to the manufacturer's protocol. Cells from MLNs were labeled with anti-CD3 and anti-CD4 antibodies and stained for intracytoplasmic IL-13, IL-17A, IFN-g, and IL-10. Cells from MLNs were labeled with anti-CD11c, anti-MHC class II (MHCII), anti-CD11b, anti-CD103, and anti-B220 antibodies, as well as 49, 6-diamidino-2-phenylindole, to identify dendritic cell (DC) subsets. The populations were gated on 49, 6-diamidino-2-phenylindole2negative and B220
2 cells. The CD11c 1 MHCII high population was further characterized on the basis of CD103 and CD11b expression. All antibodies were obtained from BD Biosciences, eBioscience, or BioLegend (San Diego, Calif). Cells were analyzed on a FACSCalibur (BD Biosciences) with FlowJo software (TreeStar, Ashland, Ore).
Assessment of Treg cell function
MNCs were isolated from spleens of peanut-and ovalbumin (OVA)-immunized mice by means of density gradient centrifugation, as previously described. 22 MNCs were labeled with 5 mmol/L carboxyfluorescein succinimidyl ester (CFSE; eBioscience), according to the manufacturer's directions. were cocultured with peanut or OVA-and CFSE-labeled MNCs. The doses of 10 mg/mL OVA and 200 mg/mL PE were chosen based on our previous report 22 and initial titration of PE concentrations, respectively. After 5 days of coculture, numbers of divisions of CFSE-labeled MNCs were monitored using flow cytometry.
Purification of CD4
1 T cells and quantitative RT-PCR Beckman Coulter) with a purity of greater than 98%, as determined by flow cytometry. RNA was extracted from freshly sorted MLN CD4 1 T cells or jejunal tissue homogenates with TRIzol (Invitrogen, Carlsbad, Calif). cDNA was generated with the iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, Calif). Quantitative RT-PCR was performed on the ABI Prism 7500 sequence detection system (Applied Biosystems, Foster City, Calif). All primers and probes used were purchased as TaqMan Gene Expression Assays from Applied Biosystems. Fold changes were calculated by using the DD cycle threshold method.
DNA bisulfite and pyrosequencing 
Statistical analysis
ANOVA was used to evaluate differences among experimental groups. Pairwise comparisons between groups used the post hoc Tukey-Kramer highest significance difference test. P values for significance were set at .05. All results were expressed as means 6 SEMs.
RESULTS

Peanut feeding in neonates suppresses peanutinduced allergic responses
We sought to develop a means for preventing peanutinduced intestinal inflammation through induction of oral PE was fed to pups from day 228 to day 215. Sensitization was performed on days 1, 7, and 21. Challenge was performed from day 35 to day 41. B, Kinetics of the development of diarrhea after feeding PE before sensitization. C, Scores based on the severity of clinical signs were assessed 30 minutes after oral challenge. D, Serum levels of peanut-specific IgE, IgG 1 , and IgG 2a were assessed by ELISA 24 hours after the last challenge and expressed as OD of diluted serum. Results were obtained from 3 individual experiments with 4 mice per group. **P < .01 and #P < .001. n.s., Not significant. PBS/PBS/PE, Sham-fed and sham-sensitized and peanut challenged; PBS/PE/PE, sham-fed and peanut sensitized and challenged; PE0.05/PE/PE, fed low doses of PE and PE sensitized and challenged; PE0.5/PE/PE, fed high doses of PE and PE sensitized and challenged.
tolerance. Beginning at 7 days of age, pups received peanut at 0.05 or 0.5 mg/g body weight for 2 weeks before sensitization, followed by peanut sensitization and challenge. The protocol to induce oral tolerance to peanut protein and the experimental groups are indicated in Fig 1, A. Feeding low doses of PE before sensitization and challenge (PE0.05/PE/PE) did not affect development of diarrhea, as shown in PE-sensitized and challenged mice (PBS/PE/PE; Fig 1, B) . In contrast, feeding high doses of PE to the pups before sensitization and challenge (PE0.5/PE/PE) induced tolerance to peanut protein and prevented development of diarrhea (Fig 1, B) . PE0.05/ PE/PE and PBS/PE/PE mice showed higher symptom scores (Fig 1, C) and higher levels of serum PE-specific IgE, IgG 1 , and IgG 2a (Fig 1, D) compared with those seen in control animals (PBS/PBS/PE). Feeding high doses of PE to PEsensitized and challenged mice significantly reduced symptom scores (Fig 1, C) and levels of serum PE-specific IgE, IgG 1 , and IgG 2a compared with those in the PE0.05/PE/PE and PBS/PE/PE groups (Fig 1, D) . Together, these results demonstrated that feeding high doses of PE to neonates before sensitization induced tolerance to peanut protein, whereas feeding low doses of PE did not.
Early feeding of peanut alters the number of Treg cells and FoxP3 expression in MLN CD4
1 T cells and jejunum Treg cells are involved in allergic sensitization to foods and modify the adaptive immune response, but mechanisms remain unclear. 23 We monitored numbers of Treg cells and expression of the Treg cell-associated gene Foxp3 in MLN CD4
1 T cells and in the jejunum by flow cytometry, RT-PCR, and immunohistochemistry. We demonstrated a 10-fold reduction in Foxp3 mRNA expression in MLN CD4
1 T cells from PE-sensitized and challenged mice compared with control mice (Fig 2, A) . Feeding high but not low doses of peanut before sensitization significantly increased Foxp3 mRNA expression in MLN CD4
1 T cells (Fig 2, A) . FoxP3 protein was localized to the lamina propria of jejunal tissues, and higher numbers of FoxP3 1 cells were seen in the lamina propria of jejunal tissue in PE0.5/PE/PE mice compared with those in PBS/PE/PE and mice per group. SSC, Side scatter; FSC, forward scatter. Magnification 3200. *P < .05 and **P < .01. n.s., Not significant.
PE0
.05/PE/PE mice (Fig 2, B and C) . Percentages of CD4
1
CD25
1 FoxP3 1 in MLNs were decreased in PBS/PE/PE mice (30% 6 1.1%) compared with those in control PBS/PBS/PE mice (43% 6 1.5% ; Fig 2, D) . Feeding high doses of PE before sensitization markedly increased the percentages of CD4
1
CD25
1 FoxP3 1 cells in MLNs (63% 6 2.1%) compared with those in control PBS/PE/PE mice (Fig 2, D) . However, feeding low doses of PE did not increase the percentages of CD4
1
CD25
1 FoxP3 1 cells in MLNs (36% 6 1.2%). These data indicated that numbers of Treg cells and FoxP3 expression were associated with induction of oral tolerance to peanut protein.
Early feeding of peanut alters cytokine and transcription factor expression in MLN CD4
1 T cells and jejunum A number of specific cytokines have been implicated in the development of allergic disorders, including food allergy and asthma. 7, 24 We measured levels of cytokine and transcription factor mRNA expression in jejunal tissue. Sham feeding and PE sensitization and challenge resulted in increased Il13 and Il17a and decreased Tgfb mRNA expression without effects on Ifng and Il10 mRNA expression in jejunal tissue compared with control values (PBS/ PBS/PE; Fig 3, A) . Feeding high but not low doses of PE before cells from MLNs. Results were from 3 independent experiments. SSC, Side scatter; FSC, forward scatter. *P < .05 and **P < .01. n.s., Not significant.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 sensitization decreased Il13 and Il17a and increased Tgfb mRNA expression; Ifng and Il10 mRNA expression was not altered compared with that in control mice (PBS/PE/PE; Fig 3, A) . In parallel, expression of the lineage-specific transcription factors Gata3 and RAR-related orphan receptor gamma t (RORgt) mRNA in jejunal tissue was significantly decreased in mice fed high doses of PE compared with control (PBS/PE/PE) mice; levels of expression of Tbx21 mRNA were not altered in mice fed high doses of PE compared with control (PBS/PE/PE) mice (Fig 3, B) . Similarly, feeding high but not low doses of PE before sensitization decreased the percentages of CD3 
IL-17A
1 cells (from 1.03% 6 0.08% to 0.64 6 % 0.09%) in MLNs compared with those in control (PBS/PE/PE) mice (Fig 3, C) . Percentages of CD3 
IL-10
1 cells in MLNs also were increased (from 0.89% 6 0.11% to 1.13% 6 0.12%) but did not reach statistical significance in mice fed high doses of PE compared with control (PBS/PE/PE) mice (Fig 3, C) . 1 DCs (from 6.22% 6 0.16% to 9.31% 6 0.46%) in MLNs compared with control PBS/PE/PE mice (Fig 4 and see Fig E1) 1 DCs were associated with induction of oral tolerance to peanut protein.
Antigen-specific suppression of CD4
1 CD25 1 cells
A functional assay was carried out in vitro to determine whether Treg cell suppressive function was antigen specific. Spleen MNCs from PE-sensitized BALB/c mice proliferated in response to PE in a dose-dependent manner; based on initial studies, the optimal dose of 200 mg/mL PE was chosen. PE-induced proliferation of MNCs was markedly decreased in the presence of CD4 1 CD25
1 cells from peanut-tolerant mice compared with control mice (in the absence of CD4 1 CD25 1 cells; from 41.5% 6 0.9% to 21.8% 6 2.1%, P < .05; Fig 5) . In contrast, OVA-induced proliferation of MNCs was only marginally decreased in the presence of CD4
1
CD25
1 cells from peanut-tolerant mice compared with control mice (in the absence of CD4 1 CD25 1 cells; from 40.5% 6 2.6% to 39% 6 1.7%, P > .05; Fig 5) . These data indicated that Treg cell suppressive activity was antigen specific.
Treatment with anti-CD25 attenuates oral tolerance to peanut protein
Given the link between Treg cell numbers and FoxP3 expression with the development of oral tolerance, we determined the consequences of reducing Treg cell numbers by administering anti-CD25 before and during the sensitization phase. Peanuttolerant WT mice (PE0.5/PE/PE) were treated with anti-mouse CD25 by means of intraperitoneal injection 3 times before and during sensitization (on days 221, 21, and 20; Fig 6, A) . The doses used were based on previous studies effectively depleting Treg cells. 19, 20 Peanut-tolerant mice treated with anti-CD25 had an increase in diarrhea and significantly increased clinical symptom scores compared with peanut-tolerant mice treated with control antibody (Fig 6, B and C) . Serum levels of peanut-specific IgE, IgG 1 , and IgG 2a were also increased in peanut-tolerant mice treated with anti-CD25 compared with tolerant mice treated with control antibody (Fig 6, D) . After treatment with anti-CD25, percentages of CD4
FoxP3
1 cells in MLNs after feeding of high doses of PE were significantly decreased (37% 6 1.5%, similar to PBS/PE/PE mice) compared with those in mice treated with control antibody (65% 6 1.2%; Fig 6, E) . Anti-CD25 administration depleted CD4
1
CD25
1 T cells from both the spleen and peripheral blood. CD4
1
CD25
1 T-cell numbers decreased by approximately 20-fold (from 2.29% to 0.12%) and 10-fold (from 5.17% to 0.51%) from spleen and peripheral blood, respectively, as detected 1 day after the second injection of anti-CD25 (Fig 6, F) . Peanut-tolerant mice treated with anti-CD25 increased Il13 and Il17a and decreased Tgfb mRNA expression without impairing Ifng and Il10 mRNA expression in jejunal tissue compared with that seen in tolerant mice treated with control IgG (Fig 6, G) . In parallel, Gata3 and RORgt mRNA in the tissues were significantly increased in tolerant mice treated with anti-CD25. Tbx21 mRNA expression was not altered in tolerant mice treated with anti-CD25 (Fig 6, H) . Together, these data demonstrated that peanut-tolerant mice treated with anti-CD25 reversed the ability to be tolerized with reappearance of all clinical, cellular, and molecular manifestations of peanut sensitization, indicating that Treg cells played an important role in the regulation of intestinal allergic responses and maintenance of tolerance to a food allergen.
Foxp3 DNA demethylation is associated with induction of tolerance
To investigate the involvement of epigenetic mechanisms in the development of oral tolerance to peanut protein, we assessed Foxp3 methylation in genomic DNA from MLN CD4
1 T cells at individual CpG sites by means of bisulfite pyrosequencing. Because Foxp3 demethylation at conserved noncoding DNA sequence (CNS) 2 is required for stable Foxp3 expression, [25] [26] [27] we targeted CpG sites at CNS2 of the first intron of the Foxp3 gene (see Fig E2 in and sham-sensitized and PE-challenged control mice (Fig 7) . In parallel to induction of tolerance, levels of Foxp3 methylation in 7 of the 9 CpG sites in the intronic 1 region were significantly reduced, almost to baseline levels (Fig 7) . Levels of Foxp3 methylation were not altered in mice fed low doses of PE before sensitization and challenge, except for CpG positions 222 and 219, compared with sham-fed and PE-sensitized and challenged mice (Fig 7) . Foxp3 methylation at the 225 position site was unchanged among the 4 groups. Measurements of Foxp3 methylation at the 223 position failed because of high CpG sum deviation. These data indicated FoxP3 demethylation at CNS2 was associated with induction of tolerance to peanut protein.
DISCUSSION
Oral tolerance refers to a state of local and systemic immune unresponsiveness induced by oral administration of soluble antigens, such as food proteins. It has been applied therapeutically to prevent or treat a number of immune-mediated diseases, including allergic disorders, in particular food allergy, 23 and autoimmune diseases. 28 To induce tolerance, targeting the adaptive immune response and antigen-specific responses is required. The lamina propria; gut-associated lymphoid tissues, such as Peyer patches; and gut-draining MLNs are the major sites of antigen uptake by DCs that encounter and activate naive T cells in the MLNs. 11 MLN cells are initiators of oral tolerance induction and are considered critical to the process. 11, 29 We established oral tolerance to peanut protein in an experimental model of peanut allergy to directly define events in the gastrointestinal tract and MLNs. We found that feeding high but not low doses of peanut to neonatal mice before peanut sensitization and challenge induced a state of tolerance to peanut protein. These data demonstrated that tolerance to peanut can be effectively induced but that tolerance induction is dependent on the amount of antigen fed. Translating such an animal study to human subjects is clearly difficult. Nevertheless, based on this mouse study, it is estimated that if infants at 7 or 8 months of age introduced peanut, about 0.3 g/d in the diet, beneficial desensitization to peanut protein can ensue. 30, 31 The timing of initial feeding and the amount of allergen fed can be critical determinants for inducing tolerance in infants. 32 Recent clinical studies have emerged demonstrating the effectiveness of early feeding of peanut to nonsensitized infants, which decreased the development of peanut allergy over the ensuing 4 to 5 years. 33 Tolerance lasted for the 1 year children were monitored after cessation of peanut ingestion, 34 but the molecular and epigenetic mechanisms underlying the benefits remain to be clarified.
Multiple immune cells and mediators are implicated in the pathogenesis of food allergy. 6, [35] [36] [37] A critical subset includes populations of Treg cells, which are involved in the suppression of immune responses and maintenance of immune homeostasis. Although there are several forms of Treg cells, FoxP3 1 naturally occurring regulatory T (nTreg) cells and FoxP3
1 inducible regulatory T (iTreg) cells are 2 well-defined subsets. 38 nTreg cells are selected in the thymus as a consequence of their reactivity to selfantigens, whereas iTreg cells are generated from naive CD4 T cells in the peripheral immune system and can differentiate into other helper T cells under inflammatory conditions. 39, 40 FoxP3 is a specific marker of Treg cells and serves as a lineage specification transcriptional factor of Treg cells. In both mice and human subjects mutations of FoxP3 result in a complex syndrome of immune dysregulation and enteropathy. 41, 42 Acquired states of FoxP3 deficiency leading to loss of Treg cell function have also been associated with allergic diseases, such as asthma. 43 In mice depletion of FoxP3 1 Treg cells resulted in autoimmune inflammation and colitis. 44 Taken together, the data point to the central role of Treg cells in controlling allergic and autoimmune manifestations in different target organs.
In the present study we focused on T-cell populations present in the jejunal tissue and in the MLNs, the primary inductive sites for oral tolerance; tolerogenic potential is largely confined to the MLNs. 29 We demonstrated that tolerance induction was associated with increases in numbers of CD4
1
CD25
1 FoxP3 1 cells in the MLNs and FoxP3 mRNA and protein expression in MLN CD4
1 T cells and in the jejunum. It has been suggested that low doses of antigen favor generation of Treg cells, whereas higher doses tend to favor induction of anergy or deletion. 45 Antigens, such as peanut protein, are acquired in the lamina propria of the small intestine and are carried to the MLNs by CD103 1 DCs.
23 CD103 1 DCs induce the development of iTreg cells, which suppress proallergic T H 2 responses and regulate tolerance. In this study we observed increases in the numbers of Treg cells in the MLNs, as well as increases in the numbers of CD103
1 DCs after feeding of high-dose peanut. In contrast, lower numbers of MLN CD103 1 DCs were seen after feeding of low doses of peanut. Because CD103
1 DCs play an important role in maintenance of intestinal homeostasis through iTreg cell generation, 46 the lower numbers of CD103 1 DCs after low-dose feeding can account in part for the lower number of Treg cells and failure of tolerance induction. These data indicate that Treg cells expressing FoxP3 can attenuate allergic responses to food antigens in sensitized mice, and the findings are consistent with reports of oral tolerance induced after a high-dose feeding regimen. 29 Treg cells were depleted after administration of anti-CD25 before and during the sensitization phase to confirm the role of J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 development of autoimmune disease, 47 and by contrast, adoptive transfer of CD4
1
CD25
1 T cells into CD4 T cell-deficient mice enabled oral tolerance induction in a model of contact hypersensitivity. 48 Interestingly, oral tolerance to antigen could be induced by iTreg cells but not nTreg cells, implying in vivo peripheral conversion of naive CD4
1 T cells into iTreg cells. 14 Recently, we have shown that both nTreg and iTreg cells can suppress lung inflammation in an experimental model of asthma and that both populations of Treg cells have the capacity to convert into potent effector cells through different cytokine-driven pathways. 49 Cytokines play an important role in antigen-induced adaptive immune responses in food allergy models. 16 In the present study we demonstrated that with tolerance induction, decreased percentages of IL-13 1 and IL-17 1 MLN CD4 1 T cells were found without alterations in IFN-g 1 or IL-10 1 CD4 1 T cells. Tolerant mice showed decreased Il13 and Il17a mRNA expression and increased Tgfb mRNA expression in the jejunum without altering Ifng or Il10 expression. These data indicated that the cytokine changes associated with allergic responses in the jejunum were effectively attenuated with tolerance induction. TGF-b, retinoic acid, and microbial antigens promote differentiation and expansion of peripheral Treg cells from naive CD4 1 T cells. 50 TGF-b is a key cytokine in the generation of FoxP3 1 Treg cells in MLNs. 51 Our results showed that oral tolerance induction was accompanied by enhanced TGF-b responses but not IL-10, which are consistent with the findings of Mucida et al, 52 demonstrating that orally induced tolerance is dependent on TGF-b but not IL-10. Nonetheless, there are conflicting data on the role of IL-10 in Treg cell-mediated immune suppression and tolerance, perhaps in part because of the models used and dose-dependent effects of IL-10. 53 Epigenetic modifications, such as DNA methylation, histone acetylation, and chromatin remodeling of critical gene loci, are involved in allergic airway disease and food allergy. [54] [55] [56] The stability of FoxP3 expression in Treg cells is controlled by DNA methylation. 57 Transcriptional silencing of Foxp3 through hypermethylation of CpG islands in the promoter and intronic regions has been identified in patients with allergic disease, including asthma, 58, 59 and has been associated with reduced Treg cell function. By measuring demethylation of TSDR in Foxp3, prenatal modulation of Treg cell numbers was suggested. 60 Foxp3 hypermethylation in peripheral blood DNA was associated with diminished Treg cell function and increased asthma severity in children exposed to polycyclic aromatic hydrocarbons. 59 In a trial of oral immunotherapy to peanut, ''resensitization'' was associated with increased methylation of CpG in the Foxp3 locus of isolated Treg cells. 35 It is interesting to note that farm milk consumption, which has been associated with asthma-protective effects, was associated with higher FoxP3 demethylation and higher Treg cell numbers, 61 as seen here in the PE-tolerant mice. These studies and our results suggest that tolerance induction to food protein is associated with epigenetic modification, DNA methylation of Foxp3.
Conserved noncoding DNA sequence (CNS) elements at the Foxp3 TSDR locus encode information defining the size, composition, and stability of Treg cells. 25 CNS2, although dispensible for induction of Foxp3, 25 was required for Foxp3 expression in the progeny of dividing Treg cells, 25, 26 and CNS2 deficiency markedly impaired Foxp3 expression. 25, 26 Foxp3 binds to CNS2 in a CpG DNA demethylation-dependent manner, conferring Treg cell lineage stability; both demethylation of the CpG island in CNS2 and Foxp3 binding to CNS2 were associated with stable examined. Results were obtained from 2 independent experiments. *P < .05 and **P < .01. n.s., Not significant.
expression of Foxp3. 25, 27, 62 We analyzed Foxp3 methylation at the intronic 1 region of CNS2 by means of bisulfite pyrosequencing. We found that tolerance to peanut protein was associated with Foxp3 demethylation in MLN CD4
1 T cells. This suggests that tolerance induction was involved in or associated with epigenetic regulation of Foxp3 methylation. Although Foxp3 demethylation was shown in MLN CD4
1 T cells and not isolated Treg cells, Foxp3 demethylation of TSDR, a factor promoting or stabilizing Foxp3 gene transcription and expression, was restricted to Treg cells. To directly link the changes in and extent of Foxp3 methylation, as well as differential methylation at individual CpG sites within the TSDR to antigen-specific iTreg cell function and tolerance induction will require further study. Taken together, the studies identify epigenetic regulation of Treg cell function as a potential target for tolerance induction and an opportunity for translational studies in human subjects. 
